147 related articles for article (PubMed ID: 37217383)
1. Is SLC34A2 Associated With Concomitant Calcium Metabolism Disorder in Pulmonary Alveolar Microlithiasis (PAM)?
Pascual-González Y; Luburich P; Cuevas E; Vicens-Zygmunt V
Arch Bronconeumol; 2023 Jul; 59(7):469-470. PubMed ID: 37217383
[No Abstract] [Full Text] [Related]
2. New insights in the genetic variant spectrum of SLC34A2 in pulmonary alveolar microlithiasis; a systematic review.
Jönsson ÅLM; Hilberg O; Simonsen U; Christensen JH; Bendstrup E
Orphanet J Rare Dis; 2023 May; 18(1):130. PubMed ID: 37259144
[TBL] [Abstract][Full Text] [Related]
3. A novel compound heterozygous mutation in the SLC34A2 gene causes pulmonary alveolar microlithiasis.
Liu Q; Ju X; Guo T; Peng H
QJM; 2024 Apr; 117(4):293-296. PubMed ID: 38070491
[No Abstract] [Full Text] [Related]
4. Impaired phosphate transport in SLC34A2 variants in patients with pulmonary alveolar microlithiasis.
Jönsson ÅLM; Hernando N; Knöpfel T; Mogensen S; Bendstrup E; Hilberg O; Christensen JH; Simonsen U; Wagner CA
Hum Genomics; 2022 Apr; 16(1):13. PubMed ID: 35443721
[TBL] [Abstract][Full Text] [Related]
5. SLC34A2 gene mutation may explain comorbidity of pulmonary alveolar microlithiasis and aortic valve sclerosis.
Jönsson ÅL; Hilberg O; Bendstrup EM; Mogensen S; Simonsen U
Am J Respir Crit Care Med; 2012 Feb; 185(4):464. PubMed ID: 22336687
[No Abstract] [Full Text] [Related]
6. Pulmonary Alveolar Microlithiasis.
Saito A; McCormack FX
Clin Chest Med; 2016 Sep; 37(3):441-8. PubMed ID: 27514591
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary alveolar microlithiasis: report of two brothers with the same illness and review of literature.
Al-Sardar H; Al-Habbo DJ; Al-Hayali RM
BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24686795
[TBL] [Abstract][Full Text] [Related]
8. Modeling pulmonary alveolar microlithiasis by epithelial deletion of the Npt2b sodium phosphate cotransporter reveals putative biomarkers and strategies for treatment.
Saito A; Nikolaidis NM; Amlal H; Uehara Y; Gardner JC; LaSance K; Pitstick LB; Bridges JP; Wikenheiser-Brokamp KA; McGraw DW; Woods JC; Sabbagh Y; Schiavi SC; Altinişik G; Jakopović M; Inoue Y; McCormack FX
Sci Transl Med; 2015 Nov; 7(313):313ra181. PubMed ID: 26560359
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis and serum FGF23 level in a patient with pulmonary alveolar microlithiasis.
Olauson H; Brandenburg V; Larsson TE
Endocrine; 2010 Apr; 37(2):244-8. PubMed ID: 20960258
[TBL] [Abstract][Full Text] [Related]
10. A pedigree with pulmonary alveolar microlithiasis: a clinical case report and literature review.
Ma T; Ren J; Yin J; Ma Z
Cell Biochem Biophys; 2014 Sep; 70(1):565-72. PubMed ID: 24817643
[TBL] [Abstract][Full Text] [Related]
11. Eight novel variants in the
Jönsson ÅLM; Bendstrup E; Mogensen S; Kopras EJ; McCormack FX; Campo I; Mariani F; Escribano-Montaner A; Holm AM; Martinez-Colls MDM; Pintos-Morell G; Taillé C; Crestani B; Hilberg O; Hvarregaard Christensen J; Simonsen U
Eur Respir J; 2020 Feb; 55(2):. PubMed ID: 31831582
[TBL] [Abstract][Full Text] [Related]
12. [Pulmonary alveolar microlithiasis caused by SLC34A2 gene compound heterozygous variations in a child].
Liu DG; Zhuang SX; Zhang CC; Wang LB
Zhonghua Er Ke Za Zhi; 2022 Jul; 60(7):715-716. PubMed ID: 35768363
[TBL] [Abstract][Full Text] [Related]
13. Severe pulmonary hypertension in pulmonary alveolar microlithiasis: A comprehensive literature review.
Cueto-Robledo G; Cantero-Ceballos MD; Gonzalez-Hermosillo LM; Navarro-Vergara DI; Garcia-Cesar M; Torres-Rojas MB; Hernandez-Villa L; Serrato BG; Alfaro-Cruz A
Curr Probl Cardiol; 2024 May; 49(5):102453. PubMed ID: 38342349
[TBL] [Abstract][Full Text] [Related]
14. Novel deletion of
Dandan S; Yuqin C; Wei L; Ziheng P; Dapeng Z; Jianzhu Y; Xin X; Yonghong L; Fengjun T
J Genet; 2018 Sep; 97(4):939-944. PubMed ID: 30262706
[TBL] [Abstract][Full Text] [Related]
15. [Alveolar microlithiasis: about a new case].
Zaghba N; Hachimi KE; Benjelloun H; Yassine N
Pan Afr Med J; 2017; 28():241. PubMed ID: 29881486
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary alveolar microlithiasis.
Kosciuk P; Meyer C; Wikenheiser-Brokamp KA; McCormack FX
Eur Respir Rev; 2020 Dec; 29(158):. PubMed ID: 33246992
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis.
Huqun ; Izumi S; Miyazawa H; Ishii K; Uchiyama B; Ishida T; Tanaka S; Tazawa R; Fukuyama S; Tanaka T; Nagai Y; Yokote A; Takahashi H; Fukushima T; Kobayashi K; Chiba H; Nagata M; Sakamoto S; Nakata K; Takebayashi Y; Shimizu Y; Kaneko K; Shimizu M; Kanazawa M; Abe S; Inoue Y; Takenoshita S; Yoshimura K; Kudo K; Tachibana T; Nukiwa T; Hagiwara K
Am J Respir Crit Care Med; 2007 Feb; 175(3):263-8. PubMed ID: 17095743
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of disodium etidronate treatment in pulmonary alveolar microlithiasis.
Ozcelik U; Yalcin E; Ariyurek M; Ersoz DD; Cinel G; Gulhan B; Kiper N
Pediatr Pulmonol; 2010 May; 45(5):514-7. PubMed ID: 20425862
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary alveolar microlithiasis: two case reports and review of the literature.
Jönsson ÅL; Simonsen U; Hilberg O; Bendstrup E
Eur Respir Rev; 2012 Sep; 21(125):249-56. PubMed ID: 22941890
[TBL] [Abstract][Full Text] [Related]
20. SLC34A2 Gene mutation of pulmonary alveolar microlithiasis: report of four cases and review of literatures.
Yin X; Wang H; Wu D; Zhao G; Shao J; Dai Y
Respir Med; 2013 Feb; 107(2):217-22. PubMed ID: 23164546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
